Doctors Note Logo

Published on: 10/1/2026

Can you still get measles after vaccination, and how mild it usually is

Yes, breakthrough measles can happen after vaccination, though it is uncommon, since two MMR doses are about 97% effective and one dose is roughly 93% effective. When vaccinated people are infected, the illness is usually milder and shorter, often with lower fever, a fainter or more limited rash, fewer complications, and reduced likelihood of spreading the virus to others. Several factors still shape your personal risk and symptom severity, including how many doses you received, time since vaccination, immune system health, and how intense the exposure was, so see below for the details that matter most.

Because early measles can look like many ordinary viral illnesses, a free, instant, online symptom check can help you clarify what is likely causing your fever, rash, or cough and what step to take next. It takes only a few minutes, works anytime from your phone, and can guide you toward the right level of care before symptoms progress or you unknowingly expose someone vulnerable.

Last reviewed for medical accuracy: 10/01/2026

answer background

Explanation

Can you still get measles after vaccination, and how mild is it?

Measles is one of the most contagious viral diseases known. Thanks to the measles–mumps–rubella (MMR) vaccine, cases have plummeted worldwide. But even with vaccination, a small number of people can still catch measles. Here’s what you need to know in clear, straightforward terms—no fluff, no undue alarm.

How effective is the measles vaccine?

  • After one dose of MMR, about 93% of people develop full immunity.
  • After two doses, immunity rises to about 97%.
  • The Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) confirm these figures.

High levels of protection mean that most vaccinated people never see measles. But because no vaccine is 100% foolproof, about 3 in every 100 fully vaccinated individuals remain susceptible.

Why “breakthrough” measles happens

Breakthrough measles refers to infection in someone who has been vaccinated. Two main reasons explain why it can occur:

  1. Primary vaccine failure

    • The person’s immune system never mounted a full response after vaccination.
    • This can be due to timing (e.g., too young at first dose) or individual immune variation.
  2. Secondary vaccine failure (waning immunity)

    • Immunity gradually decreases over many years.
    • Less common with measles than with some other vaccines, but possible.

Other factors that raise risk:

  • Being vaccinated too early (before 12 months of age) when maternal antibodies interfere.
  • Having a weakened immune system (due to medication, illness, or certain medical treatments).
  • Living in or traveling to areas with large measles outbreaks, where exposure is higher.

How mild is measles after vaccination?

When vaccinated people do get measles, their symptoms are almost always less severe than those in unvaccinated individuals. Here’s how breakthrough cases tend to differ:

  • Shorter duration.
    Fever and rash often last fewer days.

  • Lower peak fever.
    High fevers over 104 °F (40 °C) are uncommon in vaccinated people.

  • Milder rash.
    Fewer spots that may be lighter in color or cover less of the body.

  • Fewer complications.
    Ear infections, pneumonia, encephalitis, and other serious complications occur much less often.

Typical symptoms in vaccinated vs. unvaccinated

Symptom Unvaccinated Person Vaccinated Person (Breakthrough)
Fever Often > 104 °F (40 °C) Usually < 104 °F
Rash duration 5–6 days 2–4 days
Rash appearance Dense, widespread Sparse or lighter
Cough / runny nose / red eyes Prominent (“3 C’s”) Milder, shorter-lived
Hospitalization risk ~ 1–2 per 1,000 cases Significantly lower
Serious complications 1 in 10 (otitis media, pneumonia) Rare

Why vaccinated cases are milder

  1. Partial immunity: Even if the immune response wasn’t strong enough to prevent infection completely, it still limits how much virus reproduces.
  2. Faster response: Memory immune cells recognize the virus and spring into action quickly, curbing severity.
  3. Lower viral load: Less virus means milder symptoms and shorter contagious period.

Who should be especially mindful?

  • Infants under 12 months (too young for routine vaccination).
  • People with weakened immune systems (HIV, chemotherapy, high-dose steroids).
  • Adults who received only one dose of MMR or whose vaccination history is unclear.
  • Travelers to regions with ongoing measles outbreaks.

If you fall into one of these groups, you may wish to talk to your doctor about getting (or re-getting) vaccinated, or about post-exposure measures if you think you’ve been exposed.

Signs it might be measles

Measles typically begins with:

  • A high fever (often over 101 °F).
  • Cough, runny nose, and red, watery eyes.
  • Koplik spots (tiny white spots) inside the mouth.
  • A red rash that usually starts on the face and spreads downward.

If you or your child have these symptoms—especially after known exposure—you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get tailored guidance.

When to seek medical attention

Most breakthrough cases resolve on their own with rest, fluids, and over-the-counter fever reducers. However, you should contact a healthcare professional if you notice:

  • Difficulty breathing or chest pain.
  • Severe headache or stiff neck.
  • Confusion, seizures, or sensitivity to light.
  • Signs of dehydration (dry mouth, reduced urination, dizziness).
  • Any symptom that feels unusually severe or life threatening.

Preventing measles in yourself and your community

  • Get two doses of MMR. That second shot is crucial to reach the highest level of protection.
  • Keep vaccinations up to date. Adults may need booster doses in certain circumstances (healthcare work, travel).
  • Maintain high community coverage. “Herd immunity” protects infants and those who can’t be vaccinated.

Even if you’ve had measles in the past, vaccination is still recommended, since natural infection doesn’t always guarantee lifelong protection.

Bottom line

Can you still get measles after vaccination? Yes—but it’s rare, and the illness is almost always much milder than in unvaccinated people. The MMR vaccine remains our best defense, cutting risk by over 90% with one dose and more than 97% with two.

If you suspect measles or any serious illness, don’t hesitate. Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker, and speak to a doctor about any signs that could be life threatening or serious. Your health—and that of your loved ones—depends on prompt evaluation.

(References)

  • * Aaby P, Jensen TG, Hansen HL, Kristiansen H, Thårup J, Poulsen A, Sodemann M, Jakobsen M, Knudsen K, Clotilde da Silva M. Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy. Lancet. 1988 Oct 8;2(8615):809-11. doi: 10.1016/s0140-6736(88)92780-8. PMID: 2902263.

  • * Wang W, O'Driscoll M, Wang Q, Zhao S, Salje H, Yu H. Dynamics of measles immunity from birth and following vaccination. Nat Microbiol. 2024 Jul;9(7):1676-1685. doi: 10.1038/s41564-024-01694-x. Epub 2024 May 13. PMID: 38740931.

  • * BUDAI J, FARKAS E, NYERGES G, CSAPO J. [ACTIVE IMMUNIZATION AGAINST MEASLES]. Orv Hetil. 1965 Jan 3;106:7-11. PMID: 14248048.

  • * KRUGMAN S. MEASLES IMMUNIZATION: COMBINED VACCINATIONS. Arch Gesamte Virusforsch. 1965;16:339-42. doi: 10.1007/BF01253834. PMID: 14322890.

  • * Hijano DR, Orenstein WA, Oliveira CR. Measles Resurgence and the Fragility of Herd Immunity: Implications for Pediatric Infectious Disease Practice. J Pediatric Infect Dis Soc. 2025 Nov 1;14(11). doi: 10.1093/jpids/piaf094. PMID: 41105102; PMCID: PMC12581858.

  • * GARD S, CARLSTROEM G, LAGERCRANTZ R, NORRBY E. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE. Arch Gesamte Virusforsch. 1965;16:315-23. doi: 10.1007/BF01253829. PMID: 14322885.

  • * KATZ SL. IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINES: FIVE YEARS' EXPERIENCE. Arch Gesamte Virusforsch. 1965;16:222-30. doi: 10.1007/BF01253813. PMID: 14322868.

  • * SPENCER IW, COSTER MB, RICHTER M, MAHER M. A FIELD EXPERIENCE OF COMBINED MEASLES, DIPHTHERIA, WHOOPING COUGH AND TETANUS IMMUNIZATION. S Afr Med J. 1964 Feb 8;38:103-8. PMID: 14128151.

  • * MARTIN CM, MANFREDONIA SJ, WEBB NC Jr, MARKHAM FS, RUEGSEGGER JM. CONTROLLED TRIAL OF LIVE MEASLES VACCINE. EFFECTS OF AGE, HISTORY OF MEASLES IN SIBLINGS, PREVACCINE ANTIBODY, AND HUMAN GAMMA-GLOBULIN ON SYMPTOMATIC AND IMMUNE RESPONSES. Am J Dis Child. 1963 Sep;106:267-79. PMID: 14057606.

  • * Clifford HD, Hayden CM, Khoo SK, Naniche D, Mandomando IM, Zhang G, Richmond P, Le Souëf PN. Impact of CD14 promoter variants on measles vaccine responses and vaccine failure in children from Australia and Mozambique. Tissue Antigens. 2013 Dec;82(6):420-2. doi: 10.1111/tan.12226. Epub 2013 Oct 21. PMID: 24147858.

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.